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Abstract Bacterial and eukaryotic nuclear RNA polymerases (RNAPs) cap RNA with the oxidized
and reduced forms of the metabolic effector nicotinamide adenine dinucleotide, NAD+ and NADH,
using NAD+ and NADH as non-canonical initiating nucleotides for transcription initiation. Here, we
show that mitochondrial RNAPs (mtRNAPs) cap RNA with NAD+ and NADH, and do so more
efficiently than nuclear RNAPs. Direct quantitation of NAD+- and NADH-capped RNA demonstrates
remarkably high levels of capping in vivo: up to ~60% NAD+ and NADH capping of yeast
mitochondrial transcripts, and up to ~15% NAD+ capping of human mitochondrial transcripts. The
capping efficiency is determined by promoter sequence at, and upstream of, the transcription start
site and, in yeast and human cells, by intracellular NAD+ and NADH levels. Our findings indicate
mtRNAPs serve as both sensors and actuators in coupling cellular metabolism to mitochondrial
transcriptional outputs, sensing NAD+ and NADH levels and adjusting transcriptional outputs
accordingly.
DOI: https://doi.org/10.7554/eLife.42179.001
Introduction
Chemical modifications of the RNA 5’-end provide a layer of ‘epitranscriptomic’ regulation, influenc-
ing RNA fate, including stability, processing, localization, and translation efficiency (Ho¨fer and
Ja¨schke, 2018; Ja¨schke et al., 2016; Ramanathan et al., 2016; Shuman, 2015). One well-charac-
terized RNA 5’-end modification is the ‘cap’ comprising 7-methylguanylate (m7G) added to many
eukaryotic messenger RNAs (Furuichi and Shatkin, 2000; Shatkin, 1976; Shuman, 1995; Wei et al.,
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1975). Recently, a new RNA 5’-end cap comprising the metabolic effector nicotinamide adenine
dinucleotide (NAD) has been shown to be added to certain RNAs isolated from bacterial, yeast, and
human cells (Cahova´ et al., 2015; Chen et al., 2009; Frindert et al., 2018; Jiao et al., 2017;
Walters et al., 2017).
In contrast to a m7G cap, which is added to nascent RNA by a capping complex that associates
with eukaryotic RNA polymerase II (RNAP II) (Ghosh and Lima, 2010; Martinez-Rucobo et al.,
2015; Shuman, 1995; Shuman, 2001; Shuman, 2015), an NAD cap is added by RNAP itself during
transcription initiation, by serving as a non-canonical initiating nucleotide (NCIN) (Bird et al., 2016)
(reviewed in Barvı´k et al., 2017; Julius et al., 2018; Vasilyev et al., 2018). NCIN-mediated NAD
capping has been demonstrated for bacterial RNAP (Bird et al., 2016; Frindert et al., 2018;
Julius and Yuzenkova, 2017; Vvedenskaya et al., 2018) and eukaryotic RNAP II (Bird et al., 2016).
Thus, whereas m7G capping occurs after transcription initiation, on formation of the ~20th phospho-
diester bond, and occurs only in organisms harboring specialized capping complexes, NAD capping
occurs in transcription initiation, on formation of the first phosphodiester bond, and because it is
performed by RNAP itself, is likely to occur in most, if not all, organisms.
NAD exists in oxidized and reduced forms: NAD+ and NADH, respectively (Figure 1A). Capping
with NAD+ has been demonstrated both in vitro and in vivo (Bird et al., 2016; Frindert et al., 2018;
Julius and Yuzenkova, 2017; Vvedenskaya et al., 2018). Capping with NADH has been demon-
strated in vitro (Bird et al., 2016; Julius and Yuzenkova, 2017).
Ja¨schke and co-workers developed a method that combines click-chemistry-mediated covalent
capture and high-throughput sequencing, ‘NAD captureSeq,’ to detect NAD+-capped RNA
(Cahova´ et al., 2015; Winz et al., 2017). Ja¨schke and co-workers used this method to identify
NAD+-capped RNAs in bacterial cells (Escherichia coli and Bacillus subtilis; Cahova´ et al., 2015;
Frindert et al., 2018). Parker, Kiledjian, and co-workers used the same method to identify NAD+-
capped RNAs in eukaryotic cells (Saccharomyces cerevisiae and human cell line HEK293T;
Jiao et al., 2017; Walters et al., 2017). Notably, the identified Saccharomyces cerevisiae NAD+-
capped RNAs included not only RNAs produced by nuclear RNAPs, but also RNAs produced by
mitochondrial RNAP (mtRNAP). The eukaryotic nuclear RNAPs–RNAP I, II, and III–are multi-subunit
RNAPs closely related in sequence and structure to bacterial RNAP (Cramer, 2002; Darst, 2001;
Ebright, 2000; Werner and Grohmann, 2011); in contrast, mtRNAPs are single-subunit RNAPs that
are unrelated in sequence and structure to multi-subunit RNAPs and, instead, are related to DNA
polymerases, reverse transcriptases, and DNA-dependent RNAPs from T7-like bacteriophages
(Cermakian et al., 1996; Cheetham and Steitz, 2000; Hillen et al., 2018; Masters et al., 1987;
McAllister and Raskin, 1993; Ringel et al., 2011; Sousa, 1996).
The identification of NAD+-capped mitochondrial RNAs in S. cerevisiae raises the question of
whether eukaryotic single-subunit mtRNAPs–like the structurally unrelated bacterial and eukaryotic
nuclear multi-subunit RNAPs–can perform NCIN-mediated capping. A recent review discussed evi-
dence supporting the hypothesis that human mtRNAP can perform NCIN capping (Julius et al.,
2018). Here, we show that single-subunit S. cerevisiae mtRNAP and human mtRNAP perform NCIN-
mediated capping with NAD+ and NADH in vitro, and do so substantially more efficiently than bac-
terial and eukaryotic multi-subunit RNAPs. Further, we show that capping efficiency is determined
by promoter sequence, we demonstrate very high levels of NAD+ and NADH capping–up to ~60%
of mitochondrial transcripts in vivo, and we demonstrate that the extents of capping in vivo, and dis-
tributions of NAD+ capping vs. NADH capping in vivo are influenced by intracellular levels of NAD+
and NADH.
Results
S. cerevisiae and human mtRNAPs cap RNA with NAD+ and NADH in
vitro
To assess whether mtRNAP can cap RNA with NAD+ and NADH, we performed in vitro transcription
experiments (Figure 1 and Figure 1—figure supplement 1). We analyzed S. cerevisiae mtRNAP
and a DNA template carrying the S. cerevisiae mitochondrial 21S promoter (Deshpande and Patel,
2014), and, in parallel, human mtRNAP and a DNA template containing a derivative of the human
mitochondrial light-strand promoter, LSPAGU (Sologub et al., 2009) (Figure 1C–D, top). We
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Figure 1. S. cerevisiae and human mtRNAPs cap RNA with NAD+ and NADH in vitro. (A) Structures of ATP, NAD+, and NADH. Grey, identical atoms;
black, distinct atoms. (B) Processing of RNA 5’ ends by RppH and NudC. A, adenosine; N+, NAD+ nicotinamide; N, NADH nicotinamide; p, phosphate.
(C and D) NCIN capping with NAD+ and NADH by S. cerevisiae mtRNAP (C) and human mtRNAP (D). Top, promoter derivatives. Middle, initial RNA
products of in vitro transcription reactions with ATP, NAD+, or NADH as initiating nucleotide and [a32P]-GTP as extending nucleotide. Bottom, full-
length RNA products of in vitro transcription reactions with ATP, NAD+, or NADH as initiating nucleotide and [a32P]-GTP, ATP, UTP, and 3’-deoxy-CTP
(C), or [a32P]-GTP, ATP, and UTP (D) as extending nucleotides. Products were treated with RppH or NudC as indicated. Grey box and arrow,
transcription start site (TSS);+31 and+17/18, position of last NTP incorporated into full-length RNA products; M, 10-nt marker.
DOI: https://doi.org/10.7554/eLife.42179.002
The following source data and figure supplement are available for figure 1:
Source data 1. Source data for Figure 1C,D.
DOI: https://doi.org/10.7554/eLife.42179.004
Source data 2. Data for Figure 1—figure supplement 1.
DOI: https://doi.org/10.7554/eLife.42179.005
Figure supplement 1. S. cerevisiae and human mtRNAPs cap RNA with NAD+ in vitro: additional data.
DOI: https://doi.org/10.7554/eLife.42179.003
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performed reactions using either ATP, NAD+, or NADH as the initiating entity and using [a32P]-GTP
as the extending nucleotide (Figure 1C–D, middle). We observed efficient formation of an initial
RNA product in all cases (Figure 1C–D, middle). The initial RNA products obtained with ATP, but
not with NAD+ or NADH, were processed by RppH, which previous work has shown to process 5’-tri-
phosphate RNAs to 5’-monophosphate RNAs (Deana et al., 2008) (Figure 1B), whereas the initial
RNA products obtained with NAD+ or NADH, but not with ATP, were processed by NudC, which
previous work has shown to process 5’-NAD+- and 5’-NADH-capped RNAs to 5’-monophosphate
RNAs (Cahova´ et al., 2015; Ho¨fer et al., 2016) (Figure 1B). The results establish that S. cerevisiae
mtRNAP and human mtRNAP are able to generate initial RNA products using NAD+ and NADH as
NCINs.
We next assessed whether the initial RNA products formed using NAD+ and NADH as NCINs can
be extended to yield full-length RNA products (Figure 1C–D, bottom, and Figure 1—figure supple-
ment 1). We performed parallel transcription experiments using either ATP, NAD+, or NADH as the
initiating entity and using [a32P]-GTP, ATP, UTP, and 3’-deoxy-CTP (Figure 1C, bottom) or [a32P]-
GTP, ATP, and UTP (Figure 1D, bottom) as extending nucleotides. We observed efficient formation
of full-length RNA products in all cases, and we observed that full-length RNA products obtained
with NAD+ or NADH, but not with ATP, were sensitive to NudC treatment (Figure 1C–D, bottom).
We also observed efficient formation of full-length RNA products in transcription experiments per-
formed using [a32P]-ATP or [32P]-NAD+ as the initiating entity and using non-radiolabeled extending
nucleotides (Figure 1—figure supplement 1). Full-length products obtained with [32P]-NAD+, but
not with [a32P]-ATP, were insensitive to treatment with alkaline phosphatase (which processes 5’
phosphates). Furthermore, NudC treatment of full-length products obtained with [32P]-NAD+ yielded
products that were sensitive to alkaline phosphatase (Figure 1—figure supplement 1). The results
establish that S. cerevisiae mtRNAP and human mtRNAP not only generate initial RNA products, but
also generate full-length RNA products, using NAD+ and NADH as NCINs.
S. cerevisiae and human mtRNAPs cap RNA with NAD+ and NADH
more efficiently than bacterial and nuclear RNAPs
We next determined the relative efficiencies of NCIN-mediated initiation vs. ATP-mediated initiation,
(kcat/KM)NCIN / (kcat/KM)ATP, for mtRNAPs (Figure 2 and Figure 2—figure supplement 1; methods as
in Bird et al., 2017). We performed reactions with S. cerevisiae mtRNAP and DNA templates carry-
ing the S. cerevisiae mitochondrial 21S promoter or 15S promoter (Figure 2A and Figure 2—figure
supplement 1), and, in parallel, with human mtRNAP and DNA templates carrying the human mito-
chondrial light-strand promoter (LSP) or heavy-strand promoter (HSP1) (Figure 2B and Figure 2—
figure supplement 1). We obtained values of (kcat/KM)NCIN / (kcat/KM)ATP of ~0.3 to ~0.4 for NCIN-
mediated initiation with NAD+ and NADH by S. cerevisiae mtRNAP and ~0.2 to ~0.6 for NCIN-medi-
ated initiation with NAD+ and NADH by human mtRNAP. These values imply that NCIN-mediated
initiation with NAD+ or NADH is up to 40% as efficient as initiation with ATP for S. cerevisiae
mtRNAP and up to 60% as efficient as initiation with ATP for human mtRNAP.
The observed efficiencies of NCIN-mediated initiation with NAD+ or NADH by mtRNAPs are sub-
stantially higher than the highest previously reported efficiencies for NCIN-mediated initiation with
NAD+ or NADH by cellular RNAPs (~15%; Bird et al., 2017; Bird et al., 2016; Vvedenskaya et al.,
2018). To enable direct comparison of efficiencies of NCIN capping by mtRNAPs vs. cellular RNAPs
on the same templates under identical reaction conditions, we performed transcription assays using
a ‘tailed’ template (Figure 2C, top) that bypasses the requirement for sequence-specific RNAP-DNA
interactions and transcription-initiation factor-DNA interactions for transcription initiation
(Dedrick and Chamberlin, 1985; Kadesch and Chamberlin, 1982). In these experiments, we
observe efficiencies of NCIN-mediated initiation with NAD+ and NADH by mtRNAP that are
fully ~10 to ~40 fold higher than efficiencies of NCIN-mediated initiation with NAD+ and NADH by
E. coli RNAP and S. cerevisiae RNAP II (Figure 2C, bottom). We conclude that S. cerevisiae mtRNAP
and human mtRNAP cap RNA with NAD+ and NADH more efficiently than bacterial RNAP and
eukaryotic nuclear RNAP II.
We next used the same tailed template and reaction conditions as in assays performed with
mtRNAPs to determine the efficiency of NCIN-mediated initiation with NAD+ and NADH for the sin-
gle-subunit RNAP of bacteriophage T7 (T7 RNAP) (Figure 2—figure supplement 2). The efficiencies
of NCIN-mediated initiation with NAD+ and NADH by T7 RNAP were nearly as high as the
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Figure 2. S. cerevisiae and human mtRNAPs cap RNA with NAD+ and NADH more efficiently than bacterial and nuclear RNAPs. (A and B) Dependence
of NCIN-mediated capping with NAD+ and NADH on [NCIN] / [ATP] ratio for S. cerevisiae mtRNAP (A) and human mtRNAP (B) (mean ± SD; n = 3).
DNA templates and representative data are shown in Figure 2—figure supplement 1. (C) Dependence of NCIN-mediated capping with NAD+ and
NADH on [NCIN] / [ATP] ratio for mtRNAPs vs. E. coli RNAP and S. cerevisiae RNAP II. Top, tailed template. Grey box and arrow indicate TSS. Bottom,
Figure 2 continued on next page
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efficiencies of NCIN-mediated initiation by mtRNAPs. We conclude that there is a quantitative differ-
ence in the efficiency of NCIN capping between members of the single-subunit RNAP family (T7
RNAP and mtRNAPs) and members of the multi-subunit RNAP family (bacterial RNAP and eukaryotic
nuclear RNAP II).
Promoter sequence determines efficiency of RNA capping by mtRNAP
In previous work, we have shown that NCIN capping with NAD+ and NADH by bacterial RNAP is
determined by promoter sequence, particularly at and immediately upstream of, the transcription
start site (TSS) (Bird et al., 2016; Vvedenskaya et al., 2018). NCIN capping by bacterial RNAP
occurs only at promoters where the base pair (nontemplate-strand base:template-strand base) at
the TSS is A:T (+1A promoters), and occurs most efficiently at the subset of +1A promoters where
the base pair immediately upstream of the TSS is purine:pyrimidine ( 1R promoters). We have fur-
ther shown that sequence determinants for NCIN capping by bacterial RNAP reside within the tem-
plate strand of promoter DNA (i.e., the strand that templates incoming nucleotide substrates)
(Vvedenskaya et al., 2018).
To determine whether the specificity for A:T at the TSS (position +1), observed with bacterial
RNAP, also is observed with mtRNAP, we assessed NAD+ capping by S. cerevisiae mtRNAP using
promoter derivatives having A:T or G:C at position +1 (Figure 3A–B). We observed NAD+ capping
in reactions performed using the promoter derivative having A:T at position +1, but not in reactions
performed using the promoter derivative having G:C at position +1 (Figure 3B), indicating specificity
for A:T at position +1. To determine whether specificity resides in the template strand for A:T at
position +1, we analyzed NAD+ capping with S. cerevisiae mtRNAP using template derivatives hav-
ing noncomplementary nontemplate- and template-strand-nucleotides (A/C or G/T) at position +1
(Figure 3B). We observed NAD+ capping only with the promoter derivative having T as the template
strand base at position +1, indicating that specificity at position +1 resides in the template strand.
To determine whether specificity for R:Y at position  1, observed with bacterial RNAP, also is
observed with mtRNAP, we analyzed NAD+ capping by S. cerevisiae mtRNAP using promoter deriv-
atives having either R:Y (A:T or G:C) or Y:R (C:G or T:A) at position  1 (Figure 3C). We observed
higher efficiencies of NAD+ capping with promoter derivatives having R:Y at position  1 than with
promoter derivatives having Y:R (Figure 3C). To determine whether specificity at position  1 resides
in the DNA template strand, we performed experiments using promoter derivatives having Y (C or
T) or R (A or G) at position  1 of the template strand and having an abasic site (*) on the nontem-
plate strand (Figure 3D). We observed higher efficiencies of NAD+ capping in reactions performed
using promoter derivatives having Y at template-strand position  1 than with those having R. Fur-
thermore, within error, the capping efficiencies for promoter derivatives having Y or R at template-
strand position  1 matched the capping efficiencies for homoduplex promoter derivatives
(Figure 3C–D), indicating that sequence information for NAD+ capping with S. cerevisiae mtRNAP
resides exclusively in the template strand.
We conclude that NCIN capping with NAD+ by mtRNAP is determined by the sequence at, and
immediately upstream of, the TSS (positions +1 and  1, respectively). We further conclude that the
sequence and strand preferences at positions +1 and  1 for NCIN capping with NAD+ by mtRNAP
Figure 2 continued
dependence of NCIN-mediated capping with NAD+ and NADH on [NCIN] / [ATP] ratio for S. cerevisiae mtRNAP (Sce mtRNAP), human mtRNAP, E.
coli RNAP (Eco RNAP) and S. cerevisiae RNAP II (Sce RNAP II) (mean ± SD; n = 3).
DOI: https://doi.org/10.7554/eLife.42179.006
The following source data and figure supplements are available for figure 2:
Source data 1. Data for Figure 2A,B.
DOI: https://doi.org/10.7554/eLife.42179.009
Source data 2. Data for Figure 2C,D, and Figure 2—figure supplement 1.
DOI: https://doi.org/10.7554/eLife.42179.010
Figure supplement 1. Dependence of NCIN-mediated capping with NAD+ and NADH on [NCIN] / [ATP] ratio for mtRNAPs: representative data.
DOI: https://doi.org/10.7554/eLife.42179.007
Figure supplement 2. S. cerevisiae and human mtRNAPs cap RNA with NAD+ and NADH at least as efficiently as bacteriophage T7 RNAP.
DOI: https://doi.org/10.7554/eLife.42179.008
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Figure 3. Promoter sequence determines efficiency of RNA capping with NAD+ by mtRNAP. (A) S. cerevisiae mitochondrial 21S promoter DNA
depicted in the context of the mtRNAP-promoter open complex. DNA nontemplate strand (NT) on top; DNA template strand (T) on bottom; Unwound,
non-base-paired DNA region, ‘transcription bubble,’ indicated by raised and lowered nucleotides; +1 and grey boxes, bases at the TSS;  1, bases
immediately upstream of the TSS (the 21S promoter is a  1Y promoter). (B) Products of transcription reactions with NAD+ as initiating nucleotide and
[a32P]-CTP as extending nucleotide for templates having complementary or non-complementary nucleotides at position +1. (C) Dependence of NAD+
capping on [NAD+] / [ATP] ratio for homoduplex templates having A:T, G:C, T:A, or C:G at position  1 relative to TSS (mean ± SD; n = 3). Red,  1R
promoters; black,  1Y promoters. (D) Dependence of NAD+ capping on [ATP] / [NAD+] ratio for heteroduplex templates having an abasic site (*) on
the DNA nontemplate strand (mean ± SD; n = 3). Red, promoters with a template-strand Y; black, promoters with a template-strand R. (E) Sequence
preferences at position  1 for S. cerevisiae mtRNAP, E. coli RNAP, and T7 RNAP. Graphs show normalized values of (kcat/KM)NAD+ / (kcat/KM)ATP
determined for homoduplex templates having A:T, G:C, T:A, or C:G at position  1 (mean ± SD; n = 3). Normalized values were calculated by dividing
the value for each individual promoter by the average value measured for  1R promoters. Data for S. cerevisiae mtRNAP are from panel C, data for E.
coli RNAP are from (Vvedenskaya et al., 2018), and data for T7 RNAP are from Figure 3—figure supplement 1.
Figure 3 continued on next page
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match the sequence and strand preferences observed for bacterial RNAP (Figure 3C–E) (Bird et al.,
2016; Vvedenskaya et al., 2018), suggesting that these sequence and strand preferences may be
universal determinants of NCIN capping with NAD+ for all RNAPs. Consistent with this hypothesis,
we find that sequence preferences for NCIN capping with NAD+ by bacteriophage T7 RNAP,
another member of the single-subunit RNAP family, match the sequence preferences observed for
S. cerevisiae mtRNAP and bacterial RNAP (Figure 3E and Figure 3—figure supplement 1). Further
consistent with this hypothesis, structural modeling suggests the basis for these sequence and strand
preferences is universal: specifically, a strict requirement for template-strand +1T for base pairing to
the NAD+ adenine moiety, and a preference for template strand  1Y for ‘pseudo’ base pairing to
the NAD+ nicotinamide moiety (Bird et al., 2016; Vvedenskaya et al., 2018).
Detection and quantitation of NAD+- and NADH-capped mitochondrial
RNA in vivo: boronate affinity electrophoresis with processed RNA and
synthetic standards
Ko¨ssel, Ja¨schke and co-workers have demonstrated that boronate affinity electrophoresis allows res-
olution of uncapped RNAs from capped RNAs–such as m7G, NAD+ and NADH–that contain a vici-
nal-diol moiety (Igloi and Ko¨ssel, 1985; Igloi and Ko¨ssel, 1987; Nu¨bel et al., 2017). However, the
procedures of Ko¨ssel, Ja¨schke and co-workers have two limitations: (i) boronate affinity electropho-
resis does not allow resolution of RNAs longer than ~200 nt, and (ii) boronate affinity electrophore-
sis, by itself, is unable to distinguish between different vicinal-diol containing cap structures (m7G,
NAD+, NADH, or others). Here, to overcome these limitations, we have combined boronate affinity
electrophoresis with use of oligodeoxynucleotide-mediated RNA cleavage (‘DNAzyme’ cleavage)
(Joyce, 2001) and use of synthetic NCIN-capped RNA standards generated using NCIN-mediated
transcription initiation in vitro (Figure 4). Use of DNAzyme cleavage enables processing of long
RNAs to yield defined, short, 5’-end-containing subfragments (Figure 4A). Use of synthetic NCIN-
capped RNA standards enables distinction between capped species (Figure 4A,D).
To detect and quantify NCIN capping with NAD+ and NADH in mitochondrial RNA isolated from
cells, we employed the following steps: (i) DNAzyme cleavage of target RNAs to generate 5’-end-
containing subfragments < 80 nt in length (Figure 4A, top); (ii) DNAzyme treatment of synthetic
NAD+- and NADH-capped RNA standards having sequences identical to RNAs of interest
(Figure 4A, bottom); (iii) boronate affinity electrophoresis of DNAzyme-generated subfragments of
mitochondrial RNA and DNAzyme-generated subfragments of synthetic NAD+- and NADH-capped
RNA standards having sequences identical to RNAs of interest (Figure 4B); and (iv) detection of
DNAzyme-generated 5’-end-containing subfragments of mitochondrial RNAs and synthetic RNA
standards by hybridization with a radiolabeled oligodeoxyribonucleotide probe (Figure 4C–D).
We selected for analysis two S. cerevisiae mitochondrial RNAs that previously had been detected
as NAD+-capped: COX2 and 21S (Walters et al., 2017). We isolated S. cerevisiae total RNA and
analyzed COX2 and 21S RNAs using the procedure described in the preceding paragraph. The
results are presented in Figures 4C–D and 5A (top). For both COX2 and 21S RNAs, we detect at
least one RNA species with electrophoretic mobility retarded as compared to that of uncapped
RNA, indicating the presence of capped RNA. Treatment with the decapping enzyme NudC elimi-
nates these species, confirming the presence of capping. Comparison of the electrophoretic mobili-
ties to those of synthetic NAD+- and NADH-capped RNA standards indicates that one of the
capped species is NAD+-capped RNA, and the other capped species, present under these growth
Figure 3 continued
DOI: https://doi.org/10.7554/eLife.42179.011
The following source data and figure supplement are available for figure 3:
Source data 1. Data for Figure 3B.
DOI: https://doi.org/10.7554/eLife.42179.013
Source data 2. Data for Figure 3C,D,E, and Figure 3—figure supplement 1.
DOI: https://doi.org/10.7554/eLife.42179.014
Figure supplement 1. Promoter sequence determines efficiency of RNA capping with NAD+: bacteriophage T7 RNAP.
DOI: https://doi.org/10.7554/eLife.42179.012
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Figure 4. Detection and quantitation of NAD+- and NADH-capped mitochondrial RNA in vivo: boronate affinity electrophoresis with DNAzyme-cleaved
cellular RNA and DNAzyme-cleaved synthetic NCIN-capped RNA standards. (A) Use of DNAzyme (DZ) to process RNA to yield a defined, short 5’-end-
containing subfragment, in parallel in vivo (red) and in vitro (blue). Uncapped, 5’-triphosphate (ppp) end generated using ATP-mediated initiation; 5’-
NAD+, NAD+-capped end generated using NAD+-mediated initiation; 5’-NADH, NADH-capped end generated using NADH-mediated initiation. (B)
Use of boronate affinity electrophoresis to resolve 5’-uncapped, 5’-NAD+, and 5’-NADH containing RNAs. Grey, structure of phenylboronic acid (PB)
polyacrylamide gel. (C) PB-polyacrylamide gel (left) and polyacrylamide gel (right) analysis of DNAzyme-generated 5’-end-containing subfragments of S.
cerevisiae mitochondrial RNA COX2. Red, observed 5’-end-containing RNA subfragments resolved by PB-polyacylamide-gel (left) or not resolved by
polyacrylamide gel (right); identities of these subfragments are defined in Panel D. (D) Comparison of electrophoretic mobilities of observed 5’-end-
containing subfragments of COX2 RNA generated in vivo to 5’-end-containing subfragments of synthetic RNA standards generated in vitro. a, NAD+-
capped RNA; b, NADH-capped RNA; c, uncapped RNA (mean ± SD; n = 3).
DOI: https://doi.org/10.7554/eLife.42179.015
The following source data is available for figure 4:
Source data 1. Data for Figure 4D.
DOI: https://doi.org/10.7554/eLife.42179.016
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Figure 5. Detection and quantitation of NAD+- and NADH-capped mitochondrial RNA in vivo: effects of intracellular NAD+ and NADH levels in S.
cerevisiae and human cells. (A) Changes in intracellular NAD+/NADH ratios result in changes in levels of NAD+- and NADH-capped mitochondrial RNA
(mean ± SD; n = 3). Gel images show representative data for S. cerevisiae COX2 RNA (left) and 21S RNA (right). Blue annotations as in Figure 4. (B)
Changes in intracellular NAD(H) levels result in changes in levels of NAD+- and NADH-capped mitochondrial RNA (mean ± SD; n = 3). Gel images show
representative data for LSP-derived RNAs. Red, NAD(H) biosynthesis inhibitor FK866; NAMPT, Nicotinamide phosphoribosyltransferase; NMNAT,
Nicotinamide mononucleotide adenylyltransferase.
DOI: https://doi.org/10.7554/eLife.42179.017
The following source data is available for figure 5:
Source data 1. Data for Figure 5 (gels).
DOI: https://doi.org/10.7554/eLife.42179.018
Source data 2. Data for Figure 5 (values of NCIN capping).
DOI: https://doi.org/10.7554/eLife.42179.019
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conditions only for COX2 RNA, is NADH-capped RNA. The results show that both COX2 and 21S
RNAs are present in NAD+-capped forms, and that COX2 RNA also is present in an NADH-capped-
form. Because the hybridization probe detects RNA fragments that contain 5’ ends generated by
transcription initiation (red subfragment depicted in Figure 4A), the detected NAD+ and NADH
caps are concluded to be at 5’ ends generated by transcription initiation, as opposed to 5’ ends
generated by RNA processing. The results confirm that S. cerevisiae mitochondrial RNAs undergo
NAD+ capping in cells, show that S. cerevisiae mitochondrial RNAs undergo NAD+ capping at 5’
ends generated by transcription initiation (as opposed to 5’ ends generated by RNA processing),
and show that S. cerevisiae mitochondrial RNAs also undergo NADH capping in cells.
The observed levels of NAD+- and NADH-capping of S. cerevisiae mitochondrial RNAs are
remarkably high. For COX2 RNA, NAD+-capped RNA comprises ~50% of the total COX2 RNA pool
and NADH-capped RNA comprises ~10% of the total COX2 RNA pool (Figures 4C–D and 5A, top).
For 21S RNA, NAD+-capped RNA comprises ~30% of the total 21S RNA pool (Figure 5A, top).
These levels of NCIN capping are ~2 to ~50 times higher than levels of NCIN-capping in exponen-
tially growing E. coli (less than 1% to ~20% for NAD+-capping; not previously detected for NADH-
capping) (Bird et al., 2016; Cahova´ et al., 2015; Nu¨bel et al., 2017; Vvedenskaya et al., 2018).
We performed analogous experiments analyzing RNAs produced by transcription from the human
mitochondrial LSP promoter (Figure 5B, top). We isolated and analyzed total RNA from HEK293T
cells. We observed an NAD+-capped species comprising ~15% of the total LSP-derived RNA pool
(Figure 5B, top). The results establish that human mitochondrial RNAs undergo NAD+ capping in
cells and show that human mitochondrial RNAs undergo NAD+ capping at 5’ ends generated by
transcription initiation (as opposed to 5’ ends generated by RNA processing).
Detection and quantitation of NAD+- and NADH-capped mitochondrial
RNA in vivo: mtRNAPs serve as both sensors and actuators in coupling
cellular metabolism to mitochondrial gene expression
Mitochondria are the primary locus of metabolism and energy transformation in the eukaryotic cell,
serving as the venue for the tricarboxylic acid cycle (TCA) cycle and oxidative phosphorylation. The
TCA cycle reduces NAD+ to NADH and oxidative phosphorylation oxidizes NADH to NAD+. Our
finding that mtRNAPs perform NCIN capping with NAD+ and NADH at efficiencies that vary in a
simple mass-action-dependent fashion with [NAD+] / [ATP] and [NADH] / [ATP] ratios in vitro (Fig-
ures 1 and 2), and our finding that mtRNAPs perform efficient NCIN capping to yield NAD+- and
NADH-capped mitochondrial RNAs in vivo (Figures 4 and 5), raise the possibility that mtRNAPs may
serve as both sensors and actuators in coupling metabolism to mitochondrial gene expression in
vivo.
As a first test of this hypothesis, we assessed whether changing intracellular [NAD+] / [NADH]
ratios results in changes in NAD+ and NADH capping of mitochondrial RNAs. We isolated total RNA
from S. cerevisiae grown under conditions that result in either high or low [NAD+] / [NADH] ratios
(Bekers et al., 2015; Canelas et al., 2008): respiration (glycerol/ethanol; aerobic) or fermentation
(glucose; anaerobic). We analyzed the same two mitochondrial RNAs as above: COX2 and 21S
(Figure 5A). We observed marked changes in levels of NAD+ and NADH capping for both analyzed
mitochondrial RNAs. For COX2 RNA, on changing from the growth condition yielding a high [NAD+]
/ [NADH] ratio to the growth condition yielding a low [NAD+] / [NADH] ratio, we observe a decrease
in levels of NAD+ capping (from ~50% to ~20%) and an anti-correlated increase in the level of NADH
capping (from ~10% to ~40%). Notably, the total level of NAD+ and NADH capping, NAD(H) cap-
ping, remains constant under the two conditions (~60%), indicating that the relative levels of NCIN-
mediated initiation and ATP-mediated initiation do not change (Figure 5A). For 21S RNA, the same
pattern is observed (Figure 5A): on changing from the growth condition yielding a high [NAD+] /
[NADH] ratio to the growth condition yielding a low [NAD+] / [NADH] ratio, the level of NAD+ cap-
ping decreases (from ~30% to ~10%), the level of NADH capping increases (from 0% to ~20%), and
the total level of NAD+ and NADH capping remains constant (~30%). The results indicate that chang-
ing the [NAD+] / [NADH] ratio changes transcription outputs in vivo.
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As a second test of this hypothesis, we assessed whether changing intracellular total NAD(H) lev-
els results in changes in NCIN capping of mitochondrial RNAs (Figure 5B). We isolated RNA from
human HEK293T cells grown under conditions yielding either high or low intracellular NAD(H) levels:
standard growth media or growth media in the presence of the NAD(H)-biosynthesis inhibitor FK866
(Hasmann and Schemainda, 2003; Khan et al., 2006). We analyzed the same LSP-derived mito-
chondrial RNA as in the preceding section (Figure 5B). On changing from the growth condition
yielding high intracellular NAD(H) levels to the growth condition yielding low NAD(H) levels, we
observe a marked change in the total level of NCIN capping (from ~15% to 0%). The results indicate
that changing NAD(H) levels changes levels of NCIN-capped mitochondrial RNAs in vivo.
Taken together, the results of the two experiments in Figure 5 indicate that mtRNAP serves as
both sensor and actuator in coupling [NAD+] / [NADH] ratios to relative levels of NAD+- and NADH-
capped mitochondrial RNAs (Figure 5A), and in coupling total NAD(H) levels to total levels of
NCIN-capped mitochondrial RNAs (Figure 5B), thereby coupling cellular metabolism to mitochon-
drial transcription outputs. We suggest that mtRNAPs serve as sensors through their mass-action-
dependence in selecting NAD+ vs. NADH vs. ATP as the initiating entity during transcription initia-
tion, and serve as actuators by incorporating NAD+ vs. NADH vs. ATP at the RNA 5’ end during
transcription initiation.
Discussion
Our results show that S. cerevisiae and human mtRNAPs cap RNA with NAD+ and NADH (Figure 1),
show that S. cerevisiae and human mtRNAPs cap RNA with NAD+ and NADH more efficiently than
bacterial and eukaryotic nuclear RNAPs (Figure 2), and show that capping efficiency by mtRNAPs is
determined by promoter sequence (Figure 3). Our results further show that the proportions of mito-
chondrial RNAs that are capped with NAD+ and NADH are remarkably high–up to ~60% (Figures 4
and 5)–and that these proportions change in response to cellular NAD+ and NADH levels (Figure 5).
We and others previously have shown that NCIN capping by cellular RNAPs has functional conse-
quences, including modulating RNA stability and modulating RNA translatability (Bird et al., 2016;
Cahova´ et al., 2015; Jiao et al., 2017). Our results here showing that S. cerevisiae and human mito-
chondrial RNAs are capped at substantially higher levels than non-mitochondrial RNAs–up to ~60%
for analyzed S. cerevisiae mitochondrial RNAs and up to ~15% for analyzed human mitochondrial
RNAs (Figures 4 and 5)–suggest that NCIN capping in mitochondria occurs at a higher efficiency,
and has a higher importance, than NCIN capping in other cellular compartments. Four other consid-
erations support this hypothesis. First, mtRNAPs are substantially more efficient at NAD+ and NADH
capping than bacterial and eukaryotic nuclear RNAPs (Figure 2C). Second, levels of NAD+ and
NADH relative to ATP in mitochondria are substantially higher than levels of NAD+ and NADH rela-
tive to ATP in bacteria and eukaryotic nuclei (Cambronne et al., 2016; Chen et al., 2016;
Park et al., 2016). Third, all S. cerevisiae and human mitochondrial promoters are +1A promoters
(18 promoters in S. cerevisiae mitochondria; two promoters in human mitochondria) (Biswas, 1999;
Chang and Clayton, 1984; Taanman, 1999), in contrast to bacterial and eukaryotic nuclear RNAP
promoters, for which approximately half are +1A promoters (Chen et al., 2013; Haberle et al.,
2014; Saito et al., 2013; Thomason et al., 2015; Tsuchihara et al., 2009). Fourth, we observe cap-
ping with both NAD+ and NADH for mitochondrial RNAs in vivo (Figures 4 and 5), whereas, to
date, capping has been observed with only NAD+ for non-mitochondrial RNAs in vivo, raising the
possibility that, in mitochondria, but not in other cellular compartments, NAD+ and NADH caps dic-
tate different RNA fates and, correspondingly, different transcription outputs.
Our results showing that levels of NAD+ and NADH capping by mtRNAP correlate with changes
in intracellular levels of NAD+ and NADH (Figure 5) indicate that mtRNAP serves as a sensor, sens-
ing [NAD+] / [ATP] and [NADH] / [ATP] ratios, when selecting initiating entities and, simultaneously,
serves as an actuator by altering RNA 5’ ends when selecting initiating entities. Because all S. cerevi-
siae and human mitochondrial promoters are +1A promoters, this dual sensor/actuator activity of
mtRNAP will occur at, and couple metabolism to gene expression at, all S. cerevisiae and human
mitochondrial promoters. This dual sensor/actuator activity of mtRNAP obviates the need for a dedi-
cated signal-processing machinery for coupling metabolism to gene expression, instead employing a
pan-eukaryotic housekeeping enzyme for signal processing. As such, this dual sensor/actuator
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activity of mtRNAP provides a remarkably economical, parsimonious mechanism of coupling metab-
olism to gene expression.
Materials and methods
Key resources table
Reagent type
(species) or
resource Designation
Source or
reference Identifiers Additional information
Strain, strain
background
(E. coli)
BL21(DE3) bacteria NEB C2527H
Strain, strain
background
(E. coli)
NiCo21(DE3) bacteria NEB C2529H
Strain, strain
background
(E. coli)
Artic Express (DE3)
bacteria
Fisher Scientific NC9444283
Strain, strain
background
(S. cerevisiae)
246.1.1
(MATa ura3 trp1 leu2 his4)
Gift of A. Vershon
Cell line
(human)
HEK293T
(human embryonic
kidney cells)
ATCC CRL-3216
Recombinant
DNA reagent
pIA900 Gift of I.
Artsimovitch
Recombinant
DNA reagent
pET NudC-His (Bird et al., 2016)
Recombinant
DNA reagent
pJJ1399 gift of J. Jaehning
Recombinant
DNA reagent
pTrcHisC-Mtf1 gift of J. Jaehning
Recombinant
DNA reagent
pPROEXHTb-POLRMT
(43–1230) 6xHis
(Ramachandran
et al., 2017)
Recombinant
DNA reagent
pPROEXHTb-TFAM
(43-245) 6xHis
(Ramachandran
et al., 2017)
Recombinant
DNA reagent
pT7TEV-HMBP4 (Yakubovskaya
et al., 2014)
Recombinant
DNA reagent
pAR1219 (Jia et al., 1996)
Sequence-based
reagent
DK64 Integrated DNA
Technologies (IDT)
tailed template with
PEG6 linker
GGCTCGCCTCGGCTCG/iSp18/
CGAGCCGAGGCGAGCGTCACCAA
Sequence-based
reagent
JB459 IDT human LSP DNA template
+ 1 AGU variant nontemplate
strand
GTGTTAGTTGGGGGGTGACTGTT
AAAAGTGCATACCGCCAAAGTATA
AAATTTGTGGGCC
Sequence-based
reagent
JB460 IDT human LSP DNA template
+ 1 AGU variant template
strand
GGCCCACAAATTTTATACTTTGGC
GGTATGCACTTTTAACAGTCACCC
CCCAACTAACAC
Sequence-based
reagent
JB469 IDT T7j2.5–35 n nontemplate
strand ( 1T)
CAGTAATACGACTCACTATTAGCGAA
GCGGGCATGCGGCCAGCCATAGC
CGATCA
Sequence-based
reagent
JB470 IDT T7j2.5–35 n template
strand ( 1A)
TGATCGGCTATGGCTGGCCGCATGCC
CGCTTCGCTAATAGTGAGTCGTA
TTACTG
Sequence-based
reagent
JB471 IDT T7j2.5–35 n nontemplate
strand ( 1A)
CAGTAATACGACTCACTATAAGCGAAGC
GGGCATGCGGCCAGCCATAG
CCGATCA
Continued on next page
Bird et al. eLife 2018;7:e42179. DOI: https://doi.org/10.7554/eLife.42179 13 of 27
Research article Biochemistry and Chemical Biology Chromosomes and Gene Expression
Continued
Reagent type
(species) or
resource Designation
Source or
reference Identifiers Additional information
Sequence-based
reagent
JB472 IDT T7j2.5–35 n template
strand ( 1T)
TGATCGGCTATGGCTGGCCGCATGCCC
GCTTCGCTTATAGTGAGTCGTATTACTG
Sequence-based
reagent
JB473 IDT T7j2.5–35 n nontemplate
strand ( 1G)
CAGTAATACGACTCACTATGAGCGAAG
CGGGCATGCGGCCAGCCATAG
CCGATCA
Sequence based
reagent
JB474 IDT T7j2.5 35 n template
strand ( 1C)
TGATCGGCTATGGCTGGCCGCATGCC
CGCTTCGCTCATAGTGAGTCGTATTACTG
Sequence-based
reagent
JB475 IDT T7j2.5–35 n nontemplate
strand ( 1C)
CAGTAATACGACTCACTATCAGCGAA
GCGGGCATGCGGCCAGCCA
TAGCCGATCA
Sequence-based
reagent
JB476 IDT T7j2.5–35 n template
strand ( 1G)
TGATCGGCTATGGCTGGCCGCATGC
CCGCTTCGCTGATAGTG
AGTCGTATTACTG
Sequence-based
reagent
JB515 IDT probe for human LSP-generated
RNA (complementary to
positions + 2 to+31)
CACCAGCCTAACCAGATTTCAA
ATTTTATC
Sequence-based
reagent
JB525 IDT probe for S. cerevisiae
21S RNA (complementary
to positions + 9 to+42)
CTATATAATAAATATTTCAAATC
TATTATTCTAC
Sequence-based
reagent
JB526 IDT S. cerevisiae 21S RNA
DNAzyme; cleaves transcript
at position + 53
ACTCCATGATTAGGCTAGCTACAA
CGACTCTTTAAATCT
Sequence-based
reagent
JB555 IDT probe for S. cerevisiae
COX2 RNA (complementary
to positions + 8 to+46)
ATCTTAACCTTTAGACTCTTTTGTC
TATTTATAATATGT
Sequence-based
reagent
JB557 IDT S. cerevisiae COX2 DNAzyme;
cleaves at position + 57
TCTTAATAAATCTAAGGCTAGCTACA
ACGAATTTTAATAAATCTT
Sequence-based
reagent
JB559 IDT human LSP-generated RNA
DNAzyme; cleaves at
position + 67
GCACTTAAACAGGCTAGCTACAA
CGAATCTCTGCCA
Sequence-based
reagent
JB560 IDT S. cerevisiae COX2  40
to + 125 nontemplate strand
oligo (for generation of
in vitro transcription template)
TATATAATAATAAATTATAAATAAATTTT
AATTAAAAGTAGTATTAACATATTATAAA
TAGACAAAAGAGTCTAAAGGTTAAGATT
TATTAAAATGTTAGATTTATTAAGATTAC
AATTAACAAC
Sequence-based
reagent
JB561 IDT S. cerevisiae COX2  40 to + 3
forward primer (for generation
of in vitro transcription template)
TATATAATAATAAATTATAAATAAATTTT
AATTAAAAGTAGT
Sequence-based
reagent
JB562 IDT S. cerevisiae COX2 + 83 to+125
reverse primer (for generation
of in vitro transcription template)
GTTGTTAATTGTAATCTTAATAAATCTAA
CATTTTAATAAATC
Sequence-based
reagent
UB1 IDT human LSP DNA template ( 43
to + 19) nontemplate strand
ATGTGTTAGTTGGGGGGTGACTGTTAA
AAGTGCATACCGCCAAAAGATAAAATT
TGAAATCTG
Sequence-based
reagent
UB2 IDT human LSP DNA template
( 43 to + 19) template
strand
CAGATTTCAAATTTTATCTTTTGGCGGT
ATGCACTTTTAACAGTCACCCCCCAAC
TAACACAT
Sequence-based
reagent
UB3 IDT human HSP1 DNA template
( 43 to + 20) nontemplate
strand
ACACACCGCTGCTAACCCCATACCCCGA
ACCAACCAAACCCCAAAGACACCCGCC
ACAGTTTA
Sequence-based
reagent
UB4 IDT human HSP1 DNA template
( 43 to + 20) template
strand
TAAACTGTGGCGGGTGTCTTTGGGGT
TTGGTTGGTTCGGGGTATGGGGTTA
GCAGCGGTGTGT
Continued on next page
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Continued
Reagent type
(species) or
resource Designation
Source or
reference Identifiers Additional information
Sequence-based
reagent
UB5 IDT S. cerevisiae 15S DNA
template ( 25 to + 1;
C-less cassette) nontemplate
strand
ATAATTTATTTATTATTATATAAGTAAT
AAATAATTGTTTTATATAATAAGAA
TTCTCCTTC
Sequence-based
reagent
UB6 IDT S. cerevisiae 15S DNA template
( 25 to + 1; C-less cassette)
template strand
GAAGGAGAATTCTTATTATATAAAACA
ATTATTTATTACTTATATAATAATAA
ATAAATTAT
Sequence-based
reagent
UB7 IDT S. cerevisiae 21S DNA
template ( 25 to + 1;
C-less cassette) nontemplate
strand
TATTATTATTATTATATATATAAGTAG
TAAAAAGTAGAATAATAGATTT
GAAATACC
Sequence-based
reagent
UB8 IDT S. cerevisiae 21S DNA
template ( 25 to + 1;
C-less cassette) template
strand
GAAGGAGACCAACCACAAACACACA
ACAACCACCAACTACTTATATAATAA
TAAATAAATTAT
Sequence-based
reagent
UB9 IDT S. cerevisiae 21S DNA
template ( 25 to + 1; C-less
and A-less cassette) nontemplate
strand
ATAATTTATTTATTATTATATAAGTAG
TTGGTGGTTGTTGTGTGTTTGTG
GTTGGTCTCCTTC
Sequence-based
reagent
UB10 IDT S. cerevisiae 21S DNA
template ( 25to + 1;
C-less and A-less cassette)
template strand
GAAGGAGACCAACCACAAACACAC
AACAACCACCAACTACTTATATAA
TAATAAATAAATTAT
Sequence-based
reagent
UB11 IDT S. cerevisiae 21S
nontemplate strand
( 1A)
ATAATTTATTTATTATTATATAAGAA
GTTGGTGGTTGTTGTGTGTTTGTG
GTTGGTCTCCTTC
Sequence-based
reagent
UB12 IDT S. cerevisiae 21S template
strand ( 1T)
GAAGGAGACCAACCACAAACACA
CAACAACCACCAACTTCTTATATA
ATAATAAATAAATTAT
Sequence-based
reagent
UB13 IDT S. cerevisiae 21S
nontemplate strand
( 1G)
ATAATTTATTTATTATTATATAAGG
AGTTGGTGGTTGTTGTGTGTTTG
TGGTTGGTCTCCTTC
Sequence-based
reagent
UB14 IDT S. cerevisiae 21S
template strand
( 1C)
GAAGGAGACCAACCACAAACACA
CAACAACCACCAACTCCTTATAT
AATAATAAATAAATTAT
Sequence-based
reagent
UB15 IDT S. cerevisiae 21S
nontemplate strand
( 1C)
ATAATTTATTTATTATTATATAAG
CAGTTGGTGGTTGTTGTGTGT
TTGTGGTTGGTCTCCTTC
Sequence-based
reagent
UB16 IDT S. cerevisiae 21S
template strand
( 1G)
GAAGGAGACCAACCACAAACACA
CAACAACCACCAACTGCTTATATA
ATAATAAATAAATTAT
Sequence-based
reagent
UB17 IDT S. cerevisiae 21S
nontemplate strand
(+1C)
ATAATTTATTTATTATTATATAAGTC
GTTGGTGGTTGTTGTGTGTTTGT
GGTTGGTCTCCTTC
Sequence-based
reagent
UB18 IDT S. cerevisiae 21S
template strand
(+1G)
GAAGGAGACCAACCACAAACACAC
AACAACCACCAACGACTTATATAA
TAATAAATAAATTAT
Sequence-based
reagent
JB527 IDT S. cerevisiae 21S
nontemplate strand
( 1 abasic)
ATAATTTATTTATTATTATATAAG/
idSp/AGTTGGTGGTTGTTGTGTGT
TTGTGGTTGGTCTCCTTC
Peptide, recombinant
protein (S. cerevisiae)
Rpo41 (mtRNAP) (Tang et al., 2009)
Peptide, recombinant
protein (S. cerevisiae)
Mtf1 (Paratkar and
Patel, 2010)
Peptide, recombinant
protein (Human)
POLRMT (mtRNAP) (Ramachandran
et al., 2017)
Continued on next page
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Continued
Reagent type
(species) or
resource Designation
Source or
reference Identifiers Additional information
Peptide, recombinant
protein (Human)
TFAM (Ramachandran
et al., 2017)
Peptide, recombinant
protein (Human)
TFB2 (Yakubovskaya
et al., 2014)
Peptide, recombinant
protein (S. cerevisiae)
RNA
polymerase II
Gift of C. Kaplan
Peptide, recombinant
protein (E. coli)
RNA polymerase
core (b’ 6xHis)
(Artsimovitch
et al., 2003)
Peptide, recombinant
protein
T7 RNA polymerase (Jia et al., 1996)
Peptide, recombinant
protein (E. coli)
NudC (Cahova´
et al., 2015)
Peptide, recombinant
protein
Phusion Flash HF
master mix
ThermoFisher F-548L
Peptide, recombinant
protein
T4 Polynucleotide
Kinase
NEB M0201L
Peptide, recombinant
protein
RNA 5’
pyrophosphohydrolase
(RppH)
NEB M0356S
Peptide, recombinant
protein
FastAP Alkaline
Phosphatase
Thermo Fisher EF0651
Commercial assay
or kit
Monarch PCR and DNA
clean up kit
NEB T1030S
Chemical compound,
drug
Nuclease-free water
(not DEPC-treated)
ThermoFisher AM9932
Chemical compound,
drug
Bacto agar VWR 90000–760
Chemical compound,
drug
Bacto tryptone VWR 90000–286
Chemical compound,
drug
Bacto yeast extract VWR 90000–726
Chemical compound,
drug
D-Glucose
monhydrate
Amresco 0643–1 kg
Chemical compound,
drug
Glycerol EMD Millipore 55069521
Chemical compound,
drug
DMEM medium Thermo Fisher 11965–092
Chemical compound,
drug
Fetal Bovine Serum Atlanta Biological S11150H
Chemical compound,
drug
dNTP solution mix,
10 mM of each NTP
NEB N0447S
Chemical compound,
drug
NTP set (ultra-pure),
100 mM solutions
GE Healthcare 27-2025-01
Chemical compound,
drug
NAD+ Roche
(Sigma-Aldrich)
10127965001
Chemical compound,
drug
NADH Roche
(Sigma-Aldrich)
10107735001
Chemical compound,
drug
Tris base (Amresco) VWR 97061–800
Chemical compound,
drug
Boric Acid (ACS grade) VWR 97061–980
Continued on next page
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Continued
Reagent type
(species) or
resource Designation
Source or
reference Identifiers Additional information
Chemical compound,
drug
EDTA disodium salt
dyhydrate
VWR 97061–018
Chemical compound,
drug
0.5 M EDTA pH 8 ThermoFisher AM9260G
Chemical compound,
drug
Dibasic Sodium
phosphate
EMD Millipore SX0715-1
Chemical compound,
drug
Sodium Chloride EMD Millipore SX0420-3
Chemical compound,
drug
Potassium Chloride EMD Millipore 7300–500 GM
Chemical compound,
drug
Sodium Citrate EMD Millipore 7810–1 KG
Chemical compound,
drug
Sodium Acetate,
trihydrate
VWR MK736406
Chemical compound,
drug
Ficoll 400 VWR AAB22095-18
Chemical compound,
drug
Polyvinylpyrrolidone EMD Millipore 7220–1 KG
Chemical compound,
drug
Diethyl Pyrocarbonate
(DEPC)
VWR AAB22753-14
Chemical compound,
drug
Formamide,
deionized
VWR EM-4610
Chemical compound,
drug
Sodium
dodecylsulfate (SDS)
VWR 97064–470
Chemical compound,
drug
Magnesium chloride
hexahydrate
VWR EM-5980
Chemical compound,
drug
Magnesium sulfate
heptahydrate
VWR EM-MX0070-1
Chemical compound,
drug
Glycerol (ACS grade) VWR EMGX0185-5
Chemical compound,
drug
Bovine Serum Albumin
(BSA) fraction V
VWR 101174–932
Chemical compound,
drug
Bromophenol Blue VWR EM-BX1410-7
Chemical compound,
drug
Xylene Cyanol Sigma-Aldrich X4126-10G
Chemical compound,
drug
Amaranth Dye VWR 200030–400
Chemical compound,
drug
Temed (JT Baker) VWR JT4098-1
Chemical compound,
drug
Ammonium Persulfate VWR 97064–594
Chemical compound,
drug
Dithiothreitol (DTT) Gold Bio DTT50
Chemical compound,
drug
Glycogen from Oyster
(type II)
Sigma-Aldrich G8751
Chemical compound,
drug
Hydrochloric Acid
(ACS plus)
Fisher Scientific A144-212
Chemical compound,
drug
Ethyl Alcohol Pharmco-AAPER 111000200
Chemical compound,
drug
GeneMate LE Quick
Dissolve agarose
BioExpress E-3119–500
Continued on next page
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Continued
Reagent type
(species) or
resource Designation
Source or
reference Identifiers Additional information
Chemical compound,
drug
SequaGel sequencing
system
National
Diagnostics
EC833
Chemical compound,
drug
Nytran SuPerCharge
Nylon Membrane
VWR 10416296
Chemical compound,
drug
SigmaSpin G25 cleanup
columns
Sigma-Aldrich S5059
Chemical compound,
drug
32P NAD+ 250 uCi Perkin Elmer BLU023X250UC
Chemical compound,
drug
g-32P ATP Easy
Tide 1 mCi
Perkin Elmer BLU502Z001MC
Chemical compound,
drug
a-32P CTP Easy
Tide 250 uCi
Perkin Elmer BLU508H250UC
Chemical compound,
drug
a-32P GTP Easy
Tide 250 uCi
Perkin Elmer BLU506H250UC
Chemical compound,
drug
a-32P UTP Easy
Tide 250 uCi
Perkin Elmer BLU507H250UC
Chemical compound,
drug
Decade Marker Thermo Fisher AM7778
Chemical compound,
drug
TRI Reagent Molecular
Research Center
TR118
Chemical compound,
drug
Acid phenol:chloroform
(CHCl3) pH 4.5
ThermoFisher AM9720
Chemical compound,
drug
FK866 hydrochloride
hyrate
Sigma-Aldrich F8557
Software, algorithm Excel Microsoft 365
Software, algorithm ImageQuant GE Healthcare TL 5.1, TL v8.2
Software, algorithm SigmaPlot Systat Software Inc. Version 10
Software, algorithm Pymol Schrodinger, LLC http://www.pymol.org
Software, algorithm Illustrator Adobe Version CS6
Other Typhoon RBG Imager GE Healthcare
Other NanoDrop 2000C
spectrophotometer
Thermo Fisher
Other UV Crosslinker Fisher Scientific FB-UVXL-1000
Other Hybridization oven 5420 VWR 97005–252
Other Sequi-Gen GT sequencing
systems (21  50) (38  30)
Bio-Rad 1653871 and 1653873
Proteins
S. cerevisiae mtRNAP (Rpo41) was prepared from E. coli strain BL21(DE3) transformed with pJJ1399
(gift of Judith A. Jaehning) using culture and induction procedures, polyethyleneimine treatment,
ammonium sulfate precipitation, Ni-sepharose, DEAE sepharose and Heparin-sepharose chromatog-
raphy as in (Tang et al., 2009). S. cerevisiae Mtf1 was prepared from E. coli strain BL21(DE3) trans-
formed with pTrcHisC-Mtf1 (Paratkar and Patel, 2010) and purified using culture and induction
procedures, polyethyleneimine treatment, ammonium sulfate precipitation, and tandem DEAE
sepharose and Ni-sepharose chromatography as in (Tang et al., 2009).
Human mtRNAP (POLRMT) and TFAM were purified from E. coli strain BL21(DE3) transformed
with pPROEXHTb-POLRMT(43–1230) 6xHis (Ramachandran et al., 2017) or pPROEXHTb-TFAM
(43-245) 6xHis (Ramachandran et al., 2017), respectively, using culture and induction procedures,
polyethyleneimine treatment, ammonium sulfate precipitation, and Ni-sepharose and heparin-
sepharose chromatography as in (Ramachandran et al., 2017). Human TFB2 was purified from E.
coli strain ArcticExpress (DE3) (Stratagene) transformed with pT7TEV-HMBP4 (Yakubovskaya et al.,
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2014), using culture and induction procedures, polyethyleneimine treatment, ammonium sulfate pre-
cipitation, Ni-sepharose and heparin-sepharose chromatography, and size exclusion chromatography
as in (Yakubovskaya et al., 2014).
T7 RNAP was prepared from E. coli strain BL21 transformed with pAR1219 using culture and
inductions procedures, SP-Sephadex, CM-Sephadex and DEAE-Sephacel chromatography as
described in (Jia et al., 1996).
E. coli RNAP core enzyme was prepared from E. coli strain NiCo21(DE3) transformed with plas-
mid pIA900 (Artsimovitch et al., 2003) using culture and induction procedures, immobilized-metal-
ion affinity chromatography on Ni-NTA agarose, and affinity chromatography on Heparin HP as in
(Artsimovitch et al., 2003).
S. cerevisiae RNA polymerase II core enzyme (gift of Craig Kaplan) was prepared as described in
(Barnes et al., 2015).
E. coli NudC was prepared from E. coli strain NiCo21(DE3) transformed with plasmid pET NudC-
His (Bird et al., 2016) using metal-ion chromatography and size-exclusion chromatography as in
(Cahova´ et al., 2015).
RNA 5’ pyrophosphohydrolase (RppH) and T4 polynucleotide kinase (PNK) were purchased from
New England Biolabs (NEB). FastAP Thermosensitive Alkaline Phosphatase was purchased from
Thermo Fisher Scientific. Molar concentrations of purified proteins were determined by light absor-
bance at 280 nm and the calculated respective molar extinction coefficients.
Oligodeoxyribonucleotides
Sequences of the oligodeoxyribonucleotides used in this work are provided in Key Resources Table.
All oligodeoxyribonucleotides were purchased from Integrated DNA Technologies (IDT) with stan-
dard desalting purification unless otherwise specified.
Linear in vitro transcription templates used for transcription assays shown in Figures 1, 2 and
3 were generated by mixing complementary equimolar amounts of nontemplate- and template-
strand DNA in 10 mM Tris HCl pH 8.0, incubating the mixture at 95˚C for 5 min, and cooling the mix-
ture by 0.5˚C per minute to 25˚C.
Transcription templates used to generate in vitro RNA standards for Northern analysis (Figures 4
and 5) were generated by PCR. Reactions contained a mixture of 5 nM template oligo, 0.5 mM for-
ward primer, 0.5 mM reverse primer, and Phusion HF Master Mix (Thermo Scientific). Reaction prod-
ucts were isolated using a Monarch PCR and DNA cleanup kit (NEB).
The radiolabeled 10-nt marker labeled ‘M’ in gel images shown in Figures 1, 4 and 5 was gener-
ated using the Decade Marker System (Thermo Fisher Scientific), PNK (NEB) and [g32P]-ATP (Perkin
Elmer; 6,000 Ci/mmol).
In vitro transcription assays
Assays performed with S. cerevisiae mtRNAP were based on procedures described in
(Deshpande and Patel, 2014). Assays performed with human mtRNAP were based on procedures
described in (Ramachandran et al., 2017).
For initial RNA product assays in Figure 1C, Figure 1—figure supplement 1, and Figure 3, 1 mM
DNA template, 1 mM S. cerevisiae mtRNAP, and 1 mM Mtf1 were incubated at 25˚C for 10 min in
Sce-mtRNAP reaction buffer (50 mM Tris-acetate pH 7.5, 100 mM potassium glutamate, 10 mM
magnesium acetate, 0.01% Tween-20, 1 mM DTT, and 5% glycerol). A mixture containing the initiat-
ing nucleotide (200 mM ATP, 1 mM NAD+, or 1 mM NADH) and extending nucleotide (10 mM of
non-radiolabeled GTP plus 6 mCi of [a32P]-GTP [Perkin Elmer; 3,000 Ci/mmol]) was added, and
assays were incubated at 25˚C for 30 min. For assays in Figure 1C, Figure 1—figure supplement
1 and radiolabeled initial products were isolated using a Nanosep 3 kDa cutoff spin concentrator
(Pall). For assays in Figure 3B, reactions were stopped with 10 ml RNA loading dye (95% deionized
formamide, 18 mM EDTA, 0.25% SDS, xylene cyanol, bromophenol blue, amaranth) and were ana-
lyzed by electrophoresis on 7.5 M urea, 1x TBE, 20% polyacrylamide gels (UreaGel System; National
Diagnostics), followed by storage-phosphor imaging (Typhoon 9400 variable-mode imager; GE Life
Science).
For the initial RNA product assays in Figure 1D and Figure 1—figure supplement 1, 1 mM DNA
template, 1 mM human mtRNAP, 1 mM TFAM, and 1 mM TFB2M were incubated at 25˚C for 10 min
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in human-mtRNAP reaction buffer (50 mM Tris-acetate pH 7.5, 50 mM sodium glutamate, 10 mM
magnesium acetate, 1 mM DTT, and 0.05% Tween-20). A mixture containing the initiating nucleotide
(200 mM ATP, 1 mM NAD+, or 1 mM NADH) and extending nucleotide (10 mM of non-radiolabeled
GTP plus 6 mCi of [a32P]-GTP at [Perkin Elmer; 3,000 Ci/mmol]) was added, and assays were incu-
bated at 25˚C for 60 min. Radiolabeled initial RNA products were isolated using a Nanosep 3 kDa
cutoff spin concentrator (Pall).
A portion of the recovered initial RNA products were mixed with either 10 U of RppH or 400 nM
NudC and incubated at 37˚C for 30 min. Reactions were stopped by addition of 10 ml RNA loading
dye. Samples were analyzed by electrophoresis on 7.5 M urea, 1x TBE, 20% polyacrylamide gels
(UreaGel System; National Diagnostics), followed by storage-phosphor imaging (Typhoon 9400 vari-
able-mode imager; GE Life Science).
For full-length product assays in Figure 1C and Figure 1—figure supplement 1 (panel B), 1 mM
DNA template, 1 mM S. cerevisiae mtRNAP, and 1 mM Mtf1 were incubated at 25˚C for 10 min in
Sce-mtRNAP reaction buffer. A mixture containing the initiating nucleotide (1 mM ATP, 1 mM
NAD+, or 1 mM NADH for Figure 1C; 200 mM non-radiolabeled ATP plus 10 mCi [g32P]-ATP [Perkin
Elmer; 6,000 Ci/mmol] or 1 mM NAD+ plus 20 mCi [a32P]-NAD+ [Perkin Elmer; 800 Ci/mmol] for Fig-
ure 1—figure supplement 1) and extending nucleotides (200 mM GTP, 200 mM 3’-deoxy-CTP, 20
mM ATP, 200 mM non-radiolabeled UTP, and 6 mCi of [a32P]-UTP [Perkin Elmer; 3000 Ci/mmol] for
Figure 1C; 200 mM GTP, 200 mM 3’-deoxy-CTP, 20 mM ATP, 200 mM UTP for Figure 1—figure sup-
plement 1) was added, and assays were incubated at 25˚C for 30 min. Reactions were stopped by
addition of stop solution (0.6 M Tris HCl pH 8.0, 18 mM EDTA, 0.1 mg/ml glycogen), samples were
extracted with acid phenol:chloroform (5:1, pH 4.5; Thermo Fisher Scientific), and RNA products
were recovered by ethanol precipitation and resuspended in NudC reaction buffer (10 mM Tris HCl
pH 8.0, 50 mM NaCl, 10 mM MgCl2, 1 mM DTT).
For full-length product assays in Figure 1D and Figure 1—figure supplement 1 (panel C), 1 mM
DNA template, 1 mM human mtRNAP, 1 mM TFAM, and 1 mM TFB2M were incubated at 25˚C for 10
min in human-mtRNAP reaction buffer. A mixture containing the initiating nucleotide (1 mM ATP, 1
mM NAD+, or 1 mM NADH for Figure 1D; 200 mM non-radiolabeled ATP plus 10 mCi [g32P]-ATP
[Perkin Elmer; 6000 Ci/mmol] or 1 mM NAD+ plus 20 mCi [a32P]-NAD+ [Perkin Elmer; 800 Ci/mmol]
for Figure 1—figure supplement 1) and extending nucleotides (200 mM GTP, 20 mM ATP, 200 mM
non-radiolabeled UTP, and 6 mCi of [a32P]-UTP [Perkin Elmer; 3000 Ci/mmol] for Figure 1D; 200 mM
GTP, 20 mM ATP, 200 mM UTP for Figure 1—figure supplement 1) was added, and assays were
incubated at 25˚C for 60 min. Reactions were stopped by addition of stop solution, samples were
extracted with acid phenol:chloroform (5:1) (pH 4.5; Thermo Fisher Scientific), RNA products were
recovered by ethanol precipitation and resuspended in NudC reaction buffer.
Full-length RNA products were incubated at 37˚C for 30 min with 400 nM NudC alone
(Figure 1C–D and Figure 1—figure supplement 1), 0.25 U FastAP Thermosensitive Alkaline Phos-
phatase alone (Figure 1—figure supplement 1), or both NudC and FastAP (Figure 1—figure sup-
plement 1). Reactions were stopped by addition of an equal volume of RNA loading dye. Samples
were analyzed by electrophoresis on 7.5 M urea, 1x TBE, 20% polyacrylamide gels (UreaGel System;
National Diagnostics), followed by storage-phosphor imaging (Typhoon 9400 variable-mode imager;
GE Life Science).
Determination of efficiency of NCIN-mediated initiation vs. ATP-
mediated initiation, (kcat/KM)NCIN / (kcat/KM)ATP,in vitro: full-length
product assays
For experiments in Figure 2A–B and Figure 2—figure supplement 1, 1 mM of template DNA, 1 mM
of mtRNAP, and 1 mM transcription factor(s) (Mtf1 for S. cerevisiae mtRNAP; TFAM and TFB2M for
human mtRNAP) were incubated at 25˚C for 10 min in Sce-mtRNAP or human reaction buffer. A mix-
ture containing 200 mM ATP, 200 mM UTP, 200 mM non-radiolabeled GTP, and 6 mCi [a32P]-GTP at
3000 Ci/mmol and NCIN (0, 50, 100, 200, 400, 800, 1600, 3200, 6400 mM) was added, and assays
were incubated at 25˚C for 30 min. Reactions were stopped by addition of an equal volume of RNA
loading dye. Samples were analyzed by electrophoresis on 7.5 M urea, 1x TBE, 20% polyacrylamide
gels (UreaGel System; National Diagnostics) supplemented with 0.2% 3-acrylamidophenylboronic
acid (Boron Molecular), followed by storage-phosphor imaging (Typhoon 9400 variable-mode
imager; GE Life Science).
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Bands corresponding to uncapped (pppRNA) and NCIN-capped (NCIN-RNA) full-length products
were quantified using ImageQuant software. The ratio of NCIN-RNA to total RNA [NCIN-RNA /
(pppRNA + NCIN RNA)] was plotted vs. the relative concentrations of NCIN vs. ATP ([NCIN] / [ATP])
on a semi-log plot (SigmaPlot) and non-linear regression was used to fit the data to the equation: y
= (ax) / (b + x); where y is [NCIN-RNA / (pppRNA + NCIN RNA)], x is ([NCIN] / [ATP]), and a and b
are regression parameters. The resulting fit yields the value of x for which y = 0.5. The relative effi-
ciency (kcat/KM)NCIN / (kcat/KM)ATP is equal to 1/x. Data for determination of relative efficiencies are
means of three technical replicates.
Determination of efficiency of NCIN-mediated initiation vs. ATP-
mediated initiation, (kcat/KM)NCIN / (kcat/KM)ATP,in vitro: initial product
assays (Bird et al., 2017)
For experiments in Figure 3C–D, and Figure 3—figure supplement 1, 1 mM of template DNA, 1
mM of RNAP, and 1 mM transcription factor(s) (Mtf1 for S. cerevisiae mtRNAP; TFAM and TFB2M for
human mtRNAP; none for T7 RNAP) were incubated at 25˚C for 10 min in Sce-mtRNAP, human
mtRNAP reaction buffer, or T7 RNAP reaction buffer (40 mM Tris HCl pH 7.9, 6 mM MgCl2, 2 mM
DTT, 2 mM Spermidine). A mixture containing 1 mM NCIN, ATP (0, 25, 50, 100, 200, 400, 800, 1600
mM), 20 mM non-radiolabeled GTP, and 6 mCi [a32P]-GTP at 3000 Ci/mmol was added, and assays
were incubated at 25˚C for 30 min. Reactions were stopped by addition of an equal volume of RNA
loading dye. Samples were analyzed by electrophoresis on 7.5 M urea, 1x TBE, 20% polyacrylamide
gels (UreaGel System; National Diagnostics) supplemented with 0.2% 3-acrylamidophenylboronic
acid (Boron Molecular), followed by storage-phosphor imaging (Typhoon 9400 variable-mode
imager; GE Life Science).
For experiments in Figure 2C and Figure 2—figure supplements 2, 200 nM of tailed template
and 500 nM RNAP (S. cerevisiae mtRNAP, human mtRNAP, S. cerevisiae RNAP II, T7 RNAP, or E.
coli RNAP) were incubated at 25˚C for 15 min in reaction buffer containing 10 mM Tris pH 8.0, 50
mM potassium glutamate, 10 mM MgCl2, 2 mM DTT, and 50 ug/ml BSA. A mixture containing NCIN
(1 mM NCIN for mtRNAPs, T7 RNAP, and E. coli RNAP; 4 mM for S. cerevisiae RNAP II), ATP (0, 25,
50, 100, 200, 400, 800, 1600 mM for mtRNAPs and S. cerevisiae RNAP II; 0, 6.25, 12.5, 25, 50, 100,
200, 400 mM for E. coli RNAP), 10 mM non-radiolabeled CTP, and 6 mCi [a32P]-CTP (Perkin Elmer;
3000 Ci/mmol) was added, and assays were incubated at 25˚C for 1 hr. Reactions were stopped by
addition of an equal volume of RNA loading dye. Samples were analyzed by electrophoresis on 7.5
M urea, 1x TBE, 20% polyacrylamide gels (UreaGel System; National Diagnostics), followed by stor-
age-phosphor imaging (Typhoon 9400 variable-mode imager; GE Life Science).
Bands corresponding to uncapped (pppApC) and NCIN-capped (NCINpC) initial RNA products
were quantified using ImageQuant software. The ratio of NCINpC to total RNA (NCINpC /
[pppApC + NCINpC]) was plotted vs. the relative concentrations of NCIN vs. ATP ([NCIN] / [ATP])
on a semi-log plot (SigmaPlot) and non-linear regression was used to fit the data to the equation: y
= (ax) / (b + x); where y is [NCINpC / (pppApC + NCINpC)], x is ([NCIN] / [ATP]), and a and b are
regression parameters. The resulting fit yields the value of x for which y = 0.5. The relative efficiency
(kcat/KM)NCIN / (kcat/KM)ATP is equal to 1/x. Data for determination of relative efficiencies are means
of three technical replicates.
Detection and quantitation of NAD+- and NADH-capped mitochondrial
RNA in vivo: isolation of total cellular RNA from S. cerevisiae
For analysis of NAD+ and NADH capping during respiration, S. cerevisiae strain 246.1.1
[(Tatchell et al., 1981); MATa ura3 trp1 leu2 his4; gift of Andrew Vershon, Rutgers University] was
grown at 30˚C in 25 ml YPEG (24 g Bacto-tryptone, 20 g Bacto-yeast extract, 30 mL ethanol, 3%
glycerol per liter) in 125 ml flasks (Bellco) shaken at 220 rpm. When cell density reached an
OD600 ~1.8 (approximately 24 hr) the cell suspension was centrifuged to collect cells (5 min, 10,000
g at 4˚C), supernatants were removed, and cell pellets were resuspended in 0.8 mL RNA extraction
buffer (0.5 mM NaOAc pH 5.5, 10 mM EDTA, 0.5% SDS).
For analysis of NAD+ and NADH capping during fermentation, S. cerevisiae strain 246.1.1 was
grown at 30˚C in 100 ml YPD [24 g Bacto-tryptone, 20 g Bacto-yeast extract, 2% (w/v) glucose per
liter] in 125 ml flasks (Bellco) with airlocks to prevent oxygenation without shaking for 42 hr. The cell
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suspension was centrifuged to collect cells (5 min, 10,000 g at 4˚C), supernatants were removed,
and cell pellets were resuspended in 0.8 mL RNA extraction buffer (0.5 mM NaOAc pH 5.5, 10 mM
EDTA, 0.5% SDS).
To extract RNA, an equal volume of acid phenol:chloroform (5:1, pH 4.5; Thermo Fisher Scientific)
was added to cells in resuspension buffer and mixed by vortexing. Samples were incubated at 65˚C
for 5 min,  80˚C for 5 min, then centrifuged (15 min, 21,000 g, 4˚C) to separate the aqueous and
organic phases. The aqueous phase was collected and acid phenol:chloroform extraction was per-
formed two more times on this solution. RNA transcripts were recovered by ethanol precipitation
and resuspended in RNase free H2O.
Detection and quantitation of NAD+- and NADH-capped mitochondrial
RNA in vivo: isolation of total cellular RNA from human cells
Human embryonic kidney HEK293T cells (obtained from ATCC, tested negative for mycoplasma)
were maintained under 5% CO2 at 37˚C in DMEM medium (Thermo Fisher Scientific) supplemented
with 10% fetal bovine serum (Atlanta Biologicals), 100 units/ml penicillin, and 100 mg/ml streptomy-
cin. HEK293T cells were seeded in 100 mm tissue-culture treated plates and grown for 72 hr at 37˚C
or seeded in 100 mm tissue-culture treated plates, grown for 24 hr at 37˚C, treated with 5 nM FK866
(Sigma Aldrich), and grown for an additional 48 hr at 37˚C. Total cellular RNA was isolated with TRI-
zol Reagent according to the manufacture’s protocol (Thermo Fisher Scientific).
Detection and quantitation of NAD+- and NADH-capped mitochondrial
RNA in vivo: DNAzyme cleavage
For analysis of NCIN capping of S. cerevisiae mitochondrial RNA, 40 mg of total cellular RNA was
mixed with 1 mM DNAzyme (JB557 for S. cerevisiae COX2 RNA; JB526 for S. cerevisiae 21S RNA) in
buffer containing 10 mM Tris pH 8.0, 50 mM NaCl, 2 mM DTT, and 10 mM MgCl2 (total volume 50
ml). When present, NudC was added to 400 nM. Reactions were incubated for 60 min at 37˚C and
100 ml of stop solution and 500 ml ethanol was added. Samples were centrifuged (30 min, 21,000 g,
4˚C), the supernatant removed, and the pellet resuspended in RNA loading dye.
For analysis of NCIN capping of human mitochondrial RNA, 40 mg of total cellular RNA was mixed
with 1 mM DNAzyme (JB559 for human LSP-generated RNA) in buffer containing 10 mM Tris pH 8.0,
50 mM NaCl, 2 mM DTT (total volume 50 ml). Samples were heated to 85˚C for 5 min, cooled to
37˚C. MgCl2 was added to a final concentration of 10 mM and, when present, NudC was added to
400 nM. Reactions were incubated for 60 min at 37˚C and 100 ml of stop solution and 500 ml ethanol
was added. Samples were centrifuged (30 min, 21,000 g, 4˚C), the supernatant removed, and the
pellet resuspended in RNA loading dye.
To prepare synthetic RNA standards non-radiolabeled full-length RNA products were generated
by in vitro transcription reactions containing 1 mM of template DNA, 1 mM of mtRNAP, 1 mM tran-
scription factor(s), 1 mM initiating nucleotide (ATP, NAD+ or NADH), 200 mM GTP, 200 mM UTP, 200
mM CTP, and 20 mM ATP. Reactions were incubated for 60 min at 25˚C, stopped by addition of stop
solution, extracted with acid phenol:chloroform (5:1, pH 4.5; Thermo Fisher Scientific) and ethanol
precipitated. Full-length RNAs were resuspended in buffer containing 10 mM Tris pH 8.0, 50 mM
NaCl, 2 mM DTT, and 10 mM MgCl2 and treated with DNAzyme as described above.
Detection and quantitation of NAD+- and NADH-capped mitochondrial
RNA in vivo: hybridization with a radiolabeled
oligodeoxyribonucleotide probe
NCIN capping of DNAzyme-generated subfragments of mitochondrial RNA were analyzed by a pro-
cedure consisting of: (i) electrophoresis on 7.5 M urea, 1x TBE, 10% polyacrylamide gels supple-
mented with 0.2% 3-acrylamidophenylboronic acid (Boron Molecular); (ii) transfer of nucleic acids to
a Nytran supercharge nylon membrane (GE Healthcare Life Sciences) using a semidry transfer appa-
ratus (Bio-Rad); (iii) immobilization of nucleic acids by UV crosslinking; (iv) incubation with a 32P-
labelled oligodeoxyribonucleotide probe complementary to the 5’-end containing subfragments of
target RNAs (JB555, COX2 RNA; JB525, 21S RNA; JB515, LSP-derived RNA; 32P-labelled using T4
polynucleotide kinase and [g32P]-ATP [Perkin Elmer]); (v) high-stringency washing, procedures as in
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(Goldman et al., 2015); and (vi) storage-phosphor imaging (Typhoon 9400 variable-mode imager;
GE Life Science).
Bands corresponding to uncapped and NCIN-capped DNAzyme-generated subfragments were
quantified using ImageQuant software. The percentages of uncapped RNA (5’-ppp), NAD+-capped
RNA (5’-NAD+), or NADH-capped RNA (5’-NADH) to total RNA were determined from three biolog-
ical replicates.
Determination of NAD(H) levels in human HEK293T cells
Cells were lysed in 400 ml of NAD/H Extraction Buffer (NAD/H Quantitation Kit, Sigma-Aldrich) and
total proteins were extracted with two freeze-thaw cycles (20 min on dry ice, 10 min at RT). Lysates
were centrifuged (10 min, 13,000 g, 4˚C), the supernatant was isolated, and the protein concentra-
tion was determined. NAD(H) was measured using a NAD/H Quantitation Kit (Sigma) from a volume
of supernatant containing 10 mg protein.
Molecules of NAD(H) per cell were calculated using a value of 300 pg total protein per cell. The
cellular concentration of NAD(H) was then estimated by using a cellular volume of ~1200 mm3 for
HEK293T cells and assuming a homogenous distribution of NAD(H) in the cell. The volume of
HEK293T cells was calculated using a value of 13 mm for the diameter of HEK293T cells, assuming
trypsinized cells adopt a spherical shape. NAD/H concentrations were determined from three bio-
logical replicates.
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